Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
136.92
-5.42 (-3.81%)
At close: Nov 21, 2025, 4:00 PM EST
136.00
-0.92 (-0.67%)
After-hours: Nov 21, 2025, 6:01 PM EST
Nutex Health Revenue
Nutex Health had revenue of $267.80M in the quarter ending September 30, 2025, with 239.87% growth. This brings the company's revenue in the last twelve months to $981.20M, up 236.03% year-over-year. In the year 2024, Nutex Health had annual revenue of $479.95M with 93.80% growth.
Revenue (ttm)
$981.20M
Revenue Growth
+236.03%
P/S Ratio
0.83
Revenue / Employee
$1,226,495
Employees
800
Market Cap
968.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 479.95M | 232.30M | 93.80% |
| Dec 31, 2023 | 247.65M | 28.35M | 12.93% |
| Dec 31, 2022 | 219.29M | -112.24M | -33.85% |
| Dec 31, 2021 | 331.53M | 57.50M | 20.98% |
| Dec 31, 2020 | 274.03M | 176.97M | 182.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NUTX News
- 4 days ago - NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS - PRNewsWire
- 5 days ago - NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS - PRNewsWire
- 5 days ago - NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS - PRNewsWire
- 5 days ago - NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS - PRNewsWire
- 4 weeks ago - NUTEX HEALTH PROVIDES CORPORATE UPDATE - PRNewsWire
- 5 weeks ago - Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman - PRNewsWire
- 5 weeks ago - NUTEX DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Nutex Health Investors to Contact the Firm Before the October 21st Deadline - GlobeNewsWire
- 6 weeks ago - NUTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health - GlobeNewsWire